https://www.selleckchem.com/pr....oducts/Erlotinib-Hyd
24% suffered from GINA step 4-5 asthma, and 5% were under biologic treatment. 31% of patients were not on regular treatment and a negligible use of oral steroid was recorded. Within the worse outcome group, a prevalence of males was detected (64 vs 29%, p=0.026); they suffered from more severe asthma (43 vs 14%, p=0.04 and were more frequently current or former smokers (62 vs 25%, p=0.038). Our report, the first including a large COVID-19 hospitalized Italian population, confirms the low prevalence of asthma. On the ot
Like
Comment
Share
